Page last updated: 2024-10-22

amitriptyline and Autosomal Dominant Juvenile Parkinson Disease

amitriptyline has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 5 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research Excerpts

ExcerptRelevanceReference
"Pretreatment of rotenone groups with AMI or IMI prevented rotenone-induced neuronal degeneration and increased striatal dopamine level with motor recovery."1.43Imipramine and amitriptyline ameliorate the rotenone model of Parkinson's disease in rats. ( Abdelkader, NF; El-Sayeh, BM; Kandil, EA; Saleh, S, 2016)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KamiƄska, K1
Lenda, T1
Konieczny, J1
Wardas, J1
Lorenc-Koci, E1
Paumier, KL1
Sortwell, CE1
Madhavan, L1
Terpstra, B1
Celano, SL1
Green, JJ1
Imus, NM1
Marckini, N1
Daley, B1
Steece-Collier, K1
Collier, TJ1
Kandil, EA1
Abdelkader, NF1
El-Sayeh, BM1
Saleh, S1
GILLINGHAM, FJ2
KALYANARAMAN, S1
SMYTHIES, JR1

Other Studies

5 other studies available for amitriptyline and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Interactions of the tricyclic antidepressant drug amitriptyline with L-DOPA in the striatum and substantia nigra of unilaterally 6-OHDA-lesioned rats. Relevance to motor dysfunction in Parkinson's disease.
    Neurochemistry international, 2018, Volume: 121

    Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Corpus Striatum; Drug Interactions; Levodo

2018
Chronic amitriptyline treatment attenuates nigrostriatal degeneration and significantly alters trophic support in a rat model of parkinsonism.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Volume: 40, Issue:4

    Topics: Adrenergic Agents; Amitriptyline; Analgesics, Non-Narcotic; Animals; Brain-Derived Neurotrophic Fact

2015
Imipramine and amitriptyline ameliorate the rotenone model of Parkinson's disease in rats.
    Neuroscience, 2016, 09-22, Volume: 332

    Topics: Amitriptyline; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antiparkinson Agents;

2016
PARKINSON'S DISEASE.
    Physiotherapy, 1963, Dec-10, Volume: 49

    Topics: Amitriptyline; Dextroamphetamine; Humans; Imipramine; Muscle Relaxants, Central; Neurosurgery; Orphe

1963
A CASE OF POSTENCEPHALITIC PARKINSONISM RESPONDING TO COMBINED SURGICAL AND MEDICINAL TREATMENT.
    Lancet (London, England), 1965, Jan-23, Volume: 1, Issue:7378

    Topics: Amitriptyline; Chlordiazepoxide; Depression; Depressive Disorder; Drug Therapy; Encephalitis; Eye Mo

1965